Dennis E. Bulman
Dennis E. Bulman
Pièce : CHEO-RI
Bureau : 613-737-7600 poste 3876
Courriel professionnel : email@example.com
Senior Scientist, CHEO Research Institute & Newborn Screening Ontario
Affiliate Member, Regenerative Medicine Program, OHRI
Associate Professor, Department of Pediatrics, Faculty of Medicine,
University of Ottawa
Research Practice Areas:
- Disease Gene Discovery
- Newborn Screening
Dr. Bulman's research interests involve the identification of genes for rare genetic disorders, the translation of these discoveries to the clinic and the implementation of new molecular testing paradigms into Newborn screening. The lab uses a variety of genetic technologies from genetic mapping, candidate Sanger sequencing, CGH, exome and whole genome sequencing.
- Our focus is to identify new genes causing Parkinson's Disease and to identify those genes responsible for PD in Eastern Ontario/Western Quebec.
- Our focus is to identify new genes causing Brachydactyly A-1.
- Our focus is to identify new genes causing Myoclonus Dystonia and to determine how mutations in the known disease-causing gene, epsilon sarcoglycan, lead to this disorder.
- Rebecca Hood
- Malcolm George MacKenzie
- Lem Racacho
- Amanda Smith - Post Doc, Fellow
- Mylene Theriault
- Ed Yeh
- Ruobing Zou
After completing a B.Sc. in Genetics and a M.Sc. in Microbiology and Immunology at the University of Western Ontario, Dr. Bulman graduated with a Ph.D. in Molecular and Medical Genetics at the University of Toronto 1993. He then went on to a faculty position at the University of Western Ontario in the Department of Clinical Neurological Sciences. In 1997 he moved to Ottawa where he joined the Ottawa Hospital Research Institute. He is certified by the Canadian College of Medical Geneticists and the American College of Medical Genetics in Clinical Molecular Genetics and is also a Diplomat of the American Board of Medical Genetics. In 2012, he joined Newborn Screening Ontario and the Children's Hospital of Eastern Ontario Research Institute.
Human genetics, Next Generation Sequencing, disease gene identification,